首页> 外国专利> Use of natural or recombinant tissue plasminogen activator for prevention and treatment of postoperative corneal healing disorders

Use of natural or recombinant tissue plasminogen activator for prevention and treatment of postoperative corneal healing disorders

机译:天然或重组组织纤溶酶原激活剂在预防和治疗术后角膜愈合疾病中的用途

摘要

Tissue plasminogen activators are used for the prevention and treatment of postoperative corneal healing disorders (haze) following photorefractive keratectomy, thermal damage of the cornea or cauterization with acids or alkalis. Prevention and treatment of postoperative corneal healing disorders (haze) following photorefractive keratectomy comprises administration of a tissue plasminogen activator. Independent claims are also included for the prevention and treatment of postoperative corneal healing disorders (haze) following (a) thermal damage of the cornea and (b) cauterization with acid or alkali by administration of a tissue plasminogen activator.
机译:组织纤溶酶原激活剂用于预防和治疗角膜屈光摘除术,角膜热损伤或酸或碱烧灼后的角膜愈合紊乱(薄雾)。预防和治疗光折射性角膜切除术后的角膜愈合紊乱(薄雾)包括组织纤溶酶原激活剂的给药。还包括独立的权利要求,用于预防和治疗(a)角膜的热损伤和(b)通过施用组织纤溶酶原激活剂用酸或碱烧灼后的术后角膜愈合病症(薄雾)。

著录项

  • 公开/公告号DE19901594A1

    专利类型

  • 公开/公告日2000-08-10

    原文格式PDF

  • 申请/专利权人 KOMPA HANNES EDGAR;

    申请/专利号DE1999101594

  • 发明设计人 KOMPA HANNES EDGAR;

    申请日1999-01-16

  • 分类号A61K38/17;

  • 国家 DE

  • 入库时间 2022-08-22 01:42:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号